naltrexone   Click here for help

GtoPdb Ligand ID: 1639

Synonyms: (-)naltrexone | naltrexone HCl | ReVia®
Approved drug
naltrexone is an approved drug (FDA (1998), UK (2011))
Compound class: Synthetic organic
Comment: This is the active isomer of naltrexone. The (+) isomer is inactive at the opioid receptors.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: naltrexone

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 70
Molecular weight 341.16
XLogP 0.43
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1CCC2(C34C1Oc1c4c(CC2N(CC3)CC2CC2)ccc1O)O
Isomeric SMILES O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
InChI InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1
InChI Key DQCKKXVULJGBQN-XFWGSAIBSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
μ receptor Primary target of this compound Hs Antagonist Antagonist 9.1 – 9.7 pKi - 1,5
pKi 9.1 – 9.7 (Ki 7.1x10-10 – 1.99x10-10 M) [1,5]
κ receptor Primary target of this compound Hs Antagonist Antagonist 8.4 – 9.4 pKi - 2,4-5
pKi 8.4 – 9.4 [2,4-5]
δ receptor Primary target of this compound Hs Antagonist Antagonist 8.0 pKi - 5
pKi 8.0 [5]
δ receptor Mm Antagonist Antagonist 6.8 pKi - 3
pKi 6.8 [3]
κ receptor Mm Antagonist Antagonist 9.2 pIC50 - 6
pIC50 9.2 [6]